Advanced Integrative Medical Science Institute

The Advanced Integrative Medical Science (AIMS) Institute is a Seattle-based clinical research center and healthcare provider specializing in oncology, psychiatry, and palliative care. The institute is a pioneer in the application of integrative therapies, including medical cannabis and ketamine-assisted psychotherapy, for patients with complex and life-threatening illnesses. AIMS is notably active in clinical research and legal advocacy, particularly regarding the 'Right to Try' access to psilocybin for terminally ill patients. Their multidisciplinary approach combines conventional medical treatments with evidence-based complementary modalities to address physical and psychological distress.